Preferred Treatment of Type 1.5 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The purpose of this research was to test whether one treatment was superior over another in the management of type 1.5 diabetes. Specifically we tested recently diagnosed antibody positive type 2 diabetic patients to determine whether treatment with rosiglitazone results in greater preservation of beta cell function compared to treatment with glyburide.
Epistemonikos ID: 4409d1043f640c49321460bfeeb79baa228e2e26
First added on: May 04, 2024